Literature DB >> 21139038

B cells in renal transplantation: pathological aspects and therapeutic interventions.

Nicholas Barnett1, Anthony Dorling, Nizam Mamode.   

Abstract

B cells are vital in renal transplantation. B2 cells are part of the adaptive immune system. Activated B cells mature into plasma cells or memory B cells: their life spans can be prolonged by niches. B cells have a wide variety of functions: antibody production, antigen presentation, cytokine production and shaping of the splenic architecture. These functions play a vital role in graft rejection, both T cell-mediated rejection and antibody-mediated rejection. Markers of B cell activity include intragraft B cell infiltration, C4d deposition and circulating donor-specific antibodies. Many therapeutic options target B cells or plasma cells. As greater understanding is gained of their appropriate use, and new agents are developed, we should see prolonged graft survival and reduced graft rejection.

Entities:  

Mesh:

Year:  2010        PMID: 21139038     DOI: 10.1093/ndt/gfq716

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection.

Authors:  Martina Seifert; Meaghan Stolk; Dietrich Polenz; Hans-Dieter Volk
Journal:  Front Immunol       Date:  2012-07-17       Impact factor: 7.561

Review 2.  Targeting Mitochondria during Cold Storage to Maintain Proteasome Function and Improve Renal Outcome after Transplantation.

Authors:  Sorena B Lo; Richard T Blaszak; Nirmala Parajuli
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 3.  Maximising living donation with paediatric blood-group-incompatible renal transplantation.

Authors:  Nizam Mamode; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2012-09-02       Impact factor: 3.714

Review 4.  Regulatory B cells: an exciting target for future therapeutics in transplantation.

Authors:  Alexandre Nouël; Quentin Simon; Christophe Jamin; Jacques-Olivier Pers; Sophie Hillion
Journal:  Front Immunol       Date:  2014-01-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.